Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Catalyst will continue to trade on NASDAQ under the ticker symbol “CBIO” after both transactions. Continent is the first marketer of pirfenidone in China for idiopathic pulmonary fibrosis ...